NO20071880L - Diagnostic Compounds - Google Patents

Diagnostic Compounds

Info

Publication number
NO20071880L
NO20071880L NO20071880A NO20071880A NO20071880L NO 20071880 L NO20071880 L NO 20071880L NO 20071880 A NO20071880 A NO 20071880A NO 20071880 A NO20071880 A NO 20071880A NO 20071880 L NO20071880 L NO 20071880L
Authority
NO
Norway
Prior art keywords
peptide
based compounds
compounds
disease
receptors
Prior art date
Application number
NO20071880A
Other languages
English (en)
Norwegian (no)
Inventor
Magne Solbakken
Alan Cuthbertson
Bente E Arbo
Alexander Gibson
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of NO20071880L publication Critical patent/NO20071880L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20071880A 2004-09-14 2007-04-13 Diagnostic Compounds NO20071880L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0420344.4A GB0420344D0 (en) 2004-09-14 2004-09-14 Diagnostic compounds
PCT/IB2005/002727 WO2006030291A2 (en) 2004-09-14 2005-09-14 Radiofluorinated peptides

Publications (1)

Publication Number Publication Date
NO20071880L true NO20071880L (no) 2007-06-13

Family

ID=33186989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071880A NO20071880L (no) 2004-09-14 2007-04-13 Diagnostic Compounds

Country Status (23)

Country Link
US (2) US7875701B2 (pl)
EP (1) EP1791571B1 (pl)
JP (1) JP4949251B2 (pl)
KR (1) KR101243016B1 (pl)
CN (1) CN101151054B (pl)
AT (1) ATE404225T1 (pl)
AU (1) AU2005283904B8 (pl)
BR (1) BRPI0515175A (pl)
CA (1) CA2578470C (pl)
DE (1) DE602005008996D1 (pl)
DK (1) DK1791571T3 (pl)
ES (1) ES2312018T3 (pl)
GB (1) GB0420344D0 (pl)
IL (1) IL181529A (pl)
MX (1) MX2007003019A (pl)
NO (1) NO20071880L (pl)
NZ (1) NZ553384A (pl)
PL (1) PL1791571T3 (pl)
PT (1) PT1791571E (pl)
RU (1) RU2396272C9 (pl)
SI (1) SI1791571T1 (pl)
WO (1) WO2006030291A2 (pl)
ZA (1) ZA200702700B (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1622830A (zh) * 2001-07-10 2005-06-01 安盛药业有限公司 肽基化合物
EP1985624A3 (en) * 2007-04-23 2008-12-24 Bayer Schering Pharma Aktiengesellschaft Single step method of radiofluorination of biologically active compounds or biomolecules
US7666392B2 (en) 2006-09-15 2010-02-23 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
EP2099499A2 (en) 2006-12-13 2009-09-16 GE Healthcare AS Synthesis of a radiofluorinated peptide using microwave activation technology
US8241606B2 (en) 2006-12-18 2012-08-14 Ge Healthcare As Synthesis of a radiofluorinated peptide using photolabile protecting groups
US8216548B2 (en) 2006-12-28 2012-07-10 Ge Healthcare As Radiofluorination methods
BRPI0721424A2 (pt) * 2007-03-01 2014-03-25 Bayer Schering Pharma Aktiengesellschaft Métodos de radiofluoração
US8444955B2 (en) 2007-09-10 2013-05-21 Ge Healthcare Limited Radiofluorination methods
US8415510B2 (en) 2008-02-28 2013-04-09 Ge Healthcare Limited Synthesis of a PEG-6 moiety from commercial low-cost chemicals
GB0905438D0 (en) * 2009-03-30 2009-05-13 Ge Healthcare Ltd Radiolabelling reagents and methods
US8834839B2 (en) * 2009-04-27 2014-09-16 General Electric Company Labeled molecular imaging agents, methods of making and methods of use
GB0910013D0 (en) * 2009-06-10 2009-07-22 Ge Healthcare Ltd PET imaging of fibogenesis
US20120229804A1 (en) 2009-12-21 2012-09-13 Medi-Physics, Inc. Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f- ion
GB201013808D0 (en) 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
CA2819347A1 (en) 2010-12-01 2012-06-07 Ge Healthcare Limited Radioconjugation method
JP6055417B2 (ja) * 2010-12-09 2016-12-27 ジーイー・ヘルスケア・リミテッド 放射性トレーサー組成物
RU2013128354A (ru) * 2010-12-21 2015-01-27 ДжиИ ХЕЛТКЕР ЛИМИТЕД Применение анализа в радиостабилизации реакций оксимного лигирования
US20130074758A1 (en) 2011-09-26 2013-03-28 Ocean Power Technologies, Inc. Anchoring apparatus for wave energy converters
WO2013048996A1 (en) 2011-09-30 2013-04-04 Ge Healthcare Limited Method for the purification of a peptide-based imaging agent precursor
WO2013048956A2 (en) * 2011-09-30 2013-04-04 Ge Healthcare Limited Solid phase extraction separation method
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
KR102205845B1 (ko) 2013-10-28 2021-01-22 삼성전자주식회사 입자에 기반한 모델링 방법 및 장치
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
KR102668112B1 (ko) 2014-12-04 2024-05-23 지이 헬쓰케어 리미티드 방사성 약제로부터의 아세트알데히드의 제거 방법
GB201518918D0 (en) * 2015-10-26 2015-12-09 Norsk Medisinsk Syklotronsenter As And Uni I Oslo Method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2165266C1 (ru) * 2000-06-28 2001-04-20 Центральный научно-исследовательский рентгенорадиологический институт Способ получения [2-18f]-2-дезоксиглюкозы
CN1622830A (zh) * 2001-07-10 2005-06-01 安盛药业有限公司 肽基化合物
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
GB0305704D0 (en) 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0317815D0 (en) 2003-07-30 2003-09-03 Amersham Health As Imaging agents

Also Published As

Publication number Publication date
WO2006030291A2 (en) 2006-03-23
JP4949251B2 (ja) 2012-06-06
WO2006030291A3 (en) 2007-06-14
RU2396272C9 (ru) 2010-12-10
PL1791571T3 (pl) 2009-01-30
PT1791571E (pt) 2008-11-19
ZA200702700B (en) 2008-09-25
US20080095701A1 (en) 2008-04-24
HK1118713A1 (en) 2009-02-20
IL181529A (en) 2015-04-30
BRPI0515175A (pt) 2008-07-08
SI1791571T1 (sl) 2009-02-28
DE602005008996D1 (de) 2008-09-25
NZ553384A (en) 2011-02-25
CN101151054B (zh) 2014-09-24
RU2396272C2 (ru) 2010-08-10
JP2008516894A (ja) 2008-05-22
AU2005283904A1 (en) 2006-03-23
EP1791571A2 (en) 2007-06-06
US7875701B2 (en) 2011-01-25
AU2005283904B2 (en) 2012-01-19
ATE404225T1 (de) 2008-08-15
US8563600B2 (en) 2013-10-22
US20110117016A1 (en) 2011-05-19
EP1791571B1 (en) 2008-08-13
MX2007003019A (es) 2007-08-07
KR20070053750A (ko) 2007-05-25
DK1791571T3 (da) 2008-12-08
ES2312018T3 (es) 2009-02-16
CA2578470C (en) 2015-09-01
AU2005283904B8 (en) 2012-02-23
CA2578470A1 (en) 2006-03-23
CN101151054A (zh) 2008-03-26
RU2007108762A (ru) 2008-10-27
KR101243016B1 (ko) 2013-03-12
GB0420344D0 (en) 2004-10-13
IL181529A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
EA202091710A1 (ru) Антитела против cd73 и способы их применения
JOP20190248A1 (ar) بروتينات ربط مولد ضد trem2 واستخداماته
BR112022004986A2 (pt) Anticorpos anti-tnfr2 e métodos de uso
JOP20210071A1 (ar) أجسام مضادة مثبّتة trem2
GEAP202215050A (en) Antibodies against signal-regulatory protein alpha and methods of use
CY1109522T1 (el) Παραγοντες απεικονισης με βαση δικυκλικο πεπτιδιο
MA64193B1 (fr) Anticorps bispécifiques se liant aux dll3 et cd3
Vallet et al. Myeloma bone disease: update on pathogenesis and novel treatment strategies
WO2006078746A3 (en) Method, compositions and classification for tumor diagnostics and treatment
MX2025000940A (es) Anticuerpos especificos para el transcrito similar a la inmunoglobulina tipo 3 (ilt3) y sus usos
WO2012087928A3 (en) Modulating agonistic tnfr antibodies
JP2013506425A5 (pl)
EP2805970A3 (en) Antibodies to GDF8 and uses thereof
PH12015500113A1 (en) Anti-kit antibodies and uses thereof
WO2020136145A3 (en) Leucocyte immunoglobulin-like receptor 2 neutralizing antibodies
MX2019012419A (es) Uso de antagonistas de klk5 para el tratamiento de una enfermedad.
WO2015200883A3 (en) Semi-synthetic nurse shark vnar libraries for making and using selective binding compounds
JP2018531624A5 (pl)
MY202395A (en) Gremlin-1 crystal structure and inhibitory antibody
EP4345168A3 (en) Methods for preparing dna reference material and controls
WO2019028182A3 (en) TREATMENT OF CANCER USING ANTIBODIES BINDING TO THE HUMAN CD134 RECEPTOR (OX40)
Matveeva et al. Initiated pseudo-[3+ 2] cycloaddition of mixed phosphonium-iodonium ylides to acetonitrile
MX2019004862A (es) Anticuerpos anti-rankl y usos de los mismos.
PL2101826T3 (pl) Znakowane izotopowo związki na bazie peptydów i ich zastosowania
Moser et al. Accessory head of the biceps tendon versus aponeurotic expansion of the supraspinatus tendon

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA